COMPOSITION: – CEFPODOXIME PROXETIL 50 MG & POTASSUIM CLAVULANATE ORAL 31.25 MG SUSPENSION
PACKING: – 4GM/30ML
M.R.P: – 115
Absorption: – De-esterification of Cefpodoxime Proxetil takes place in the gastrointestinal tract where it is absorbed and is converted to its active metabolite which is Cefpodoxime.
Metabolism: – It gets metabolised in-vivo.
Excretion: – Through urine.
Absorption: – Potassium Clavulanate is well absorbed from the gastro-intestinal tract.